ABSTRACT. Objective. Oxygen delivery through nasal cannulae to convalescent preterm infants is a common but largely unstudied practice. To learn more about current nasal cannula oxygen delivery practices, we examined the variations in oxygen delivery through nasal cannulae among the centers of the Neonatal Research Network, the frequency of prescription of low levels of oxygen, and the success of weaning to room air. We hypothesized that some infants treated with oxygen through nasal cannulae were receiving oxygen levels equivalent to those of room air.
O xygen delivery through nasal cannulae to convalescent preterm infants is a common but largely unstudied practice. There are no existing criteria regarding when personnel attempt to wean infants from oxygen or the methods of weaning used. When oxygen is delivered through a hood, the fraction of inspired oxygen (Fio 2 ) is analyzed and often weaning increments of 2% are used. In contrast, when oxygen is delivered through a nasal cannula, the precise Fio 2 is unknown and weaning practices are more variable. The actual concentration of oxygen delivered through a nasal cannula is a blend of nasally inhaled oxygen and room air entrained through the mouth and nose. The ratio of these 2 components determines the actual oxygen concentration delivered to the alveoli, termed the effective Fio 2 . The effective Fio 2 varies with minute ventilation, the inspiratory oxygen concentration in ambient air and the nasal cannula, and the ratio of mouth to nose breathing. [1] [2] [3] Benaron and Benitz 1 calculated formulae predicting oxygen delivery on the basis of assumptions about patient-controlled factors. The mathematical formulae generated by Benaron and Benitz 1 were made more accessible through transformation to tabular form as a component of the Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (STOP-ROP) trial. 4 Although these principles potentially provide a more rational basis for oxygen prescription through nasal cannulae, they have not been used widely in clinical practice. To learn more about current nasal cannula oxygen delivery practices, we examined the variations in oxygen delivery through nasal cannulae among the centers of the Neonatal Research Network, the frequency of prescription of low levels of oxygen, and the success of weaning to room air. We hypothesized that a proportion of infants treated with oxygen through nasal cannulae were receiving oxygen levels equivalent to those in room air.
METHODS
This study was nested within a randomized, controlled trial of quality improvement practices to reduce the incidence of bronchopulmonary dysplasia. Patients were eligible for the study if they had been born in a National Institute of Child Health and Human Development Neonatal Research Center, with a birth weight of Ͻ1250 g, between May 2001 and May 2002. Within the trial, extensive data on oxygen treatment practices were collected for 1508 enrolled infants. At postmenstrual ages of 35 to 37 weeks, 209 infants were tested with a timed oxygen reduction to room air, to determine their oxygen saturation in room air. Detailed methods were reported previously. 5, 6 Briefly, infants were challenged if supplemental oxygen levels were Ͻ30% at rest with oxygen saturation between 90% and 96% or were Ն30% with saturation of Ͼ96%. For infants receiving oxygen through hoods, oxygen was weaned in 2% increments. For infants receiving oxygen through nasal cannulae, flow was weaned initially in increments (for flow of 1.0 -2.0 L/minute, increments of 0.5 L/minute; for flow of 0.1-0.99 L/minute, increments of 0.1 L/minute), and then oxygen concentrations were reduced to those of room air in increments of 20%. Cannulae were removed from the nares for the remainder of the challenge. There were 2 methods of passing during the room air observation phase, ie, a rapid pass and a pass after full monitoring. Rapid pass criteria were met with successful weaning to room air with all saturation values being Ն96% for 15 minutes. If the saturation values were 90% to 95%, then the infant was monitored for 30 minutes with room air; a pass was defined when all saturation values exceeded 90% in that 30-minute period.
Two hundred nine infants were challenged. Twenty-two infants were excluded from analysis because they were treated with oxygen through a hood or had incomplete information. Therefore, data for 187 (91%) of the 209 infants who were receiving oxygen supplementation through nasal cannulae were included in this study (birth weight: 843 Ϯ 186 g, mean Ϯ SD; gestational age: 26.3 Ϯ 1.8 weeks; weight at time of study: 2014 Ϯ 369 g).
For all neonates who were receiving oxygen through nasal cannulae, effective Fio 2 values were calculated with the equations described by Benaron and Benitz, 1 as modified by the STOP-ROP study investigators 4 (Tables 1 and 2 ). A hypothetical neonate weighing 2.0 kg with nasal cannula flow of 0.03 L/minute and 30% oxygen concentration is used to illustrate the use of Tables 1  and 2 . In Table 1 , weight and flow are compared and yield a factor of 2. In Table 2 , the factor of 2 is combined with the oxygen concentration of 30% to yield a predicted effective Fio 2 of 0.21. In their calculations, Benaron and Benitz 1 assumed the following constant variables: nasal flow is constant over the inspiratory cycle, the upper airway does not serve as a reservoir, the inspiration time is 0.3 seconds, and the tidal volume is 5.0 mL/kg. To assess the value of knowing the effective Fio 2 , the outcome of the room air challenge was compared with the effective Fio 2 received before the challenge.
The institutional review boards at the 17 participating centers approved the physiologic definition of bronchopulmonary dysplasia protocol. Parental consent was obtained as required by local institutional review board policies. Continuous variables are described as mean and SD. Group differences in continuous measures were compared with Student's t test and analysis of variance. Categorical variables were assessed with frequency distributions, and group differences were compared with the 2 test. To determine the ability of the effective Fio 2 to predict the success of weaning to room air, logistic regression equations were constructed. Candidate predictor variables included gender, birth weight, gestational age, weight at the time of study, saturation before challenge, and effective Fio 2 . Various effective Fio 2 levels and combinations of prechallenge effective Fio 2 and saturation were assessed for their ability to predict successful passing of the challenge.
RESULTS
Centers differed in their methods of delivering oxygen through nasal cannulae, with 3 centers using 100% oxygen with various flow rates and 14 centers using blended oxygen with various flow rates. Of the 187 neonates who were receiving oxygen through nasal cannulae, 87 (46.5%) passed the room air challenge and 100 (53.5%) failed. The effective Fio 2 delivered before the challenge ranged from 0.21 to 0.49. As expected, the frequency of success varied, with infants treated with lower effective Fio 2 levels being more successful in passing the challenge (Fig 1) . The effective Fio 2 for those who passed was 0.23 Ϯ 0.03 (mean Ϯ SD), compared with 0.26 Ϯ 0.05 for those who failed. The success of weaning was associated with the effective Fio 2 before the challenge (P Ͻ .0001) (Fig 1) .
Prescription of oxygen with combinations of flow rates and oxygen concentrations that produced low effective Fio 2 values was common. Fifty-two infants (27.8%) were receiving oxygen concentrations and flow rates through nasal cannulae that delivered an effective Fio 2 of Ͻ0.23; 16 infants (8.6%) were receiving oxygen concentrations and flow rates that delivered an effective Fio 2 of 0.21 and thus were being prescribed room air. In contrast, among those prescribed oxygen through a hood, none was prescribed Ͻ23% oxygen.
Twenty-two infants (11.8%) were prescribed room air through nasal cannulae intentionally, with various flow rates (range: 0.13-2.00 L/minute). Fifteen (68.2%) of those 22 infants passed the challenge successfully, whereas 7 failed.
Logistic regression analysis identified effective Fio 2 and oxygen saturation before the weaning challenge as significant factors associated with successful weaning to room air (Table 3) . Gestational age and birth weight were not predictors of successful wean- ing. The combination of prechallenge saturation of Ͼ96% and effective Fio 2 of Յ0.23 identified correctly 66.3% of infants who were weaned successfully to room air (Table 4) .
DISCUSSION
Oxygen is delivered nearly exclusively through nasal cannulae for preterm infants at the postmenstrual age of 36 weeks. Fifty-two (27.8%) of the infants prescribed oxygen through nasal cannulae in this study were prescribed amounts of Ͻ23%, which would not be prescribed routinely if the same infants were in oxygen hoods. Furthermore, 72% of the infants prescribed Ͻ23% oxygen were weaned successfully to room air when challenged. The combination of prechallenge saturation of Ͼ96% and effective Fio 2 of Յ0.23 correctly identified 66.3% of infants who were weaned successfully to room air. Therefore, knowledge of the effective Fio 2 delivered through nasal cannulae may allow caretakers to identify more effectively infants who are ready for a trial of room air. Widespread clinical use of the effective Fio 2 for infants treated with nasal cannulae may make their treatment more similar to that of infants treated with oxygen in hoods.
Oxygen delivery through nasal cannulae for neonates is preferred by caregivers because of the ease of administration and the ability to feed and to care for the infant while continuing oxygen administration. Infants cared for with nasal cannulae also have increased mobility, compared with those who are in hoods, which may increase interactions with the parents, caregivers, and environment and may be developmentally beneficial. These benefits are balanced by some drawbacks, including the instability of oxygen administration in transitions between oral and nasal breathing, drying of nasal mucosa, and lack of precise knowledge about the delivered oxygen concentration. The last factor may contribute to highly variable weaning practices among institutions and physicians and to continued prescription of oxygen through nasal cannulae that delivers concentrations of oxygen that are effectively room air. Such practices might contribute to unnecessary days of oxygen delivery, hospitalization, and costs of care. Few studies have explored the delivery of oxygen through nasal cannulae to convalescent preterm infants since its use was proposed in the 1980s. 7 Fan and Voyles 8 proposed a method for estimating the concentration of delivered oxygen by matching pulse oximetry measurements in a nasal cannula with similar saturation values in an oxygen hood. Benaron and Benitz 1 proposed the technique used here in 1994, whereas Finer et al 9 proposed a similar method in 1996. Despite these recommendations, routine documentation of the estimated effective Fio 2 delivered through nasal cannulae has not been implemented in clinical practice. We speculate that in part this is because the methods of both Benaron and Benitz 1 and Finer et al 9 require calculations that are cumbersome during routine clinical care. Tables that display this information make the information more accessible and may improve nasal cannula oxygen prescription.
The use of nasal cannulae to deliver end-expiratory pressure or gas flow to reduce the frequency of apnea and desaturation has not been tested adequately, although such use has become common. Several studies have documented that nasal cannulae can deliver positive end-expiratory pressure. Locke et al 10 first described the ability of nasal cannulae to generate inadvertent positive end-distending pressure. Others later exploited this possibility as a deliberate therapeutic intervention. Courtney et al 11 documented that continuous positive airway pressure delivered through nasal cannulae led to changes in lung volume but did so at the cost of increased work of breathing and higher oxygen concentrations. Sreenan et al 12 found that nasal cannulae used at flow rates between 1.0 and 2.5 L/minute for preterm infants delivered continuous positive airway pressures as high as 8 cm H 2 O and performed equivalently to conventional continuous positive airway pressure delivery among infants who were studied at a mean weight of 1260 g. Of interest, 22 infants in the present study were treated with nasal cannulae with room air and flow rates ranging from 0.13 to 2.00 L/minute. Fifteen (68.2%) of those infants were weaned successfully to room air, but 31.8% were not. It is possible that the flow for the patients who experienced failure stabilized the airway through the administration of continuous positive airway pressure.
Our study has limitations that must be recognized. One limitation is the relatively brief period for the trial in room air (30 minutes). 5, 6 The room air challenge was designed to define bronchopulmonary dysplasia as a clinical trial end point. All infants were returned to their preexisting oxygen concentrations. Therefore, the results of the room air trial may not translate into the ability to tolerate prolonged weaning to room air. Nevertheless, the identification of a possible lower weaning limit for nasal cannula therapy may be an important step in improving oxygenweaning practices. Clinicians using this strategy should implement a longer period of observation, including sustained monitoring in room air, to ensure that short periods of adequate oxygen saturation translate to longer-term oxygenation and cardiopulmonary stability before discharge. A second limitation is that the calculation of effective Fio 2 necessarily makes assumptions about inspiratory time and tidal volume. These assumptions may not apply for specific infants, which might account for some of the infants who experienced failure but were predicted to pass. Finally, numerous vendors produce nasal cannulae with different widths. The impact of differences between devices is not known.
The calculation of effective Fio 2 is a step toward more rational prescription of oxygen through nasal cannulae for convalescent preterm neonates. Identification of the point at which the effective Fio 2 reaches 0.23 allows clinicians to identify a point at which it is logical to perform a trial of room air. Not all infants will pass the trial, but such an attempt may reduce unnecessary days with low levels of oxygen and may reduce the length of the hospital stay. 
